|
1
|
Wang YJ, Zhang SM, Zhang L, Wang CX, Dong
Q, Gao S, Huang RX, Huang YN, Lv CZ, Liu M, et al: Chinese
guidelines for the secondary prevention of ischemic stroke and
transient ischemic attack 2010. CNS Neurosci Ther. 18:93–101. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartsch JA, Teare GF, Neufeld A, Hudema N
and Muhajarine N: Secondary prevention of stroke in Saskatchewan,
Canada: ηypertension control. Int J Stroke. 8:32–38. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hankey GJ, Wong KS, Chankrachang S, Chen
C, Crimmins D, Frayne J, Kim JS, Li Y, Liou CW, Merican JS, et al:
Working Group on Stroke and Lipids Management in Asia Consensus
Panel: Management of cholesterol to reduce the burden of stroke in
Asia: consensus statement. Int J Stroke. 5:209–216. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Allen CL and Bayraktutan U: Risk factors
for ischaemic stroke. Int J Stroke. 3:105–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim JS, Nah HW, Park SM, Kim SK, Cho KH,
Lee J, Lee YS, Kim J, Ha SW, Kim EG, et al: Risk factors and stroke
mechanisms in atherosclerotic stroke: Intracranial compared with
extracranial and anterior compared with posterior circulation
disease. Stroke. 43:3313–3318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meschia JF, Worrall BB and Rich SS:
Genetic susceptibility to ischemic stroke. Nat Rev Neurol.
7:369–378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu Y, Wang J, Wu Y, Wang G and Hu B: Two
novel mutations in NOTCH3 gene causes cerebral autosomal dominant
arteriopathy with subcritical infarct and leucoencephalopathy in
two Chinese families. Int J Clin Exp Pathol. 8:1321–1327.
2015.PubMed/NCBI
|
|
8
|
Bevan S and Markus HS: Genetics of common
polygenic ischaemic stroke: current understanding and future
challenges. Stroke Res Treat. 2011:1790612011.PubMed/NCBI
|
|
9
|
Viswanathan A, Gschwendtner A, Guichard
JP, Buffon F, Cumurciuc R, O'Sullivan M, Holtmannspötter M, Pachai
C, Bousser MG, Dichgans M, et al: Lacunar lesions are independently
associated with disability and cognitive impairment in CADASIL.
Neurology. 69:172–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pescini F, Nannucci S, Bertaccini B, et
al: The cerebral autosomal-dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) scale. Stroke.
43:2871–2876. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dichgans M, Ludwig H, Müller-Höcker J,
Messerschmidt A and Gasser T: Small in-frame deletions and missense
mutations in CADASIL: 3D models predict misfolding of Notch3
EGF-like repeat domains. Eur J Hum Genet. 8:280–285. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okeda R, Arima K and Kawai M: Arterial
changes in cerebral autosomal dominan arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL) in relation to
pathogenesis of diffuse myelin loss of cerebral white matter.
Stroke. 33:2565–2569. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang SC, Jeng JS, Lee MJ and Yip PK: Notch
signaling and CADASIL. Acta Neurol Taiwan. 18:81–90.
2009.PubMed/NCBI
|
|
14
|
Joutel A, Monet M, Domenga V, Riant F and
Tournier-Lasserve E: Pathogenic mutations associated with cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy differently affect Jagged1 binding and Notch3
activity via the RBP/JK signaling Pathway. Am J Hum Genet.
74:338–347. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Domenga V, Fardoux P, Lacombe P, Monet M,
Maciazek J, Krebs LT, Klonjkowski B, Berrou E, Mericskay M, Li Z,
et al: Notch3 is required for arterial identity and maturation of
vascular smooth muscle cells. Genes Dev. 18:2730–2735. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ito D, Tanahashi N, Murata M, Sato H,
Saito I, Watanabe K and Fukuuchi Y: Notch3 gene polymorphism and
ischaemic cerebrovascular disease. J Neurol Neurosurg Psychiatry.
72:382–384. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizuno T, Makino M, Fujiwara Y and
Nakajima K: Lack of association between NOTCH3 gene polymorphism
and cerebrovascular disease in Japanese patients. Ann N Y Acad Sci.
977:252–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmidt H, Zeginigg M, Wiltgen M,
Freudenberger P, Petrovic K, Cavalieri M, Gider P, Enzinger C,
Fornage M, Debette S, et al: CHARGE consortium Neurology working
group: Genetic variants of the NOTCH3 gene in the elderly and
magnetic resonance imaging correlates of age-related cerebral small
vessel disease. Brain. 134:3384–3397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu J, Sun K, Bai Y, Zhang W, Wang X, Wang
Y, Wang H, Chen J, Song X, Xin Y, et al: Association of three-gene
interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke:
a multicenter case-control study. Hum Genet. 125:649–656. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Z, Yuan Y, Zhang W, Lv H, Hong D,
Chen B, Liu Y, Luan X, Xie S and Wu S: NOTCH3 mutations and
clinical features in 33 mainland Chinese families with CADASIL. J
Neurol Neurosurg Psychiatry. 82:534–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liao YC, Hsiao CT, Fuh JL, et al:
Characteriazation of CADASIL among the Han Chinese in Taiwan:
Distinct Genotypic and Phenotypic Profiles. PLoS One.
10:e01365012015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boulos N, Helle F, Dussaule JC, Placier S,
Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, et
al: Notch3 is essential for regulation of the renal vascular tone.
Hypertension. 57:1176–1182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Caolo V, Schulten HM, Zhuang ZW, Murakami
M, Wagenaar A, Verbruggen S, Molin DG and Post MJ: Soluble Jagged-1
inhibits neointima formation by attenuating Notch-Herp2 signaling.
Arterioscler Thromb Vasc Biol. 31:1059–1065. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pippucci T, Maresca A, Magini P, Cenacchi
G, Donadio V, Palombo F, Papa V, Incensi A, Gasparre G, Valentino
ML, et al: Homozygous NOTCH3 null mutation and impaired NOTCH3
signaling in recessive early-onset arteriopathy and cavitating
leukoencephalopathy. EMBO Mol Med. 7:848–858. 2015. View Article : Google Scholar : PubMed/NCBI
|
